X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AJANTA PHARMA with Cadila Healthcare - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AJANTA PHARMA vs CADILA HEALTHCARE - Comparison Results

CADILA HEALTHCARE 
   Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AJANTA PHARMA CADILA HEALTHCARE AJANTA PHARMA/
CADILA HEALTHCARE
 
P/E (TTM) x 21.4 37.1 57.6% View Chart
P/BV x 9.2 9.6 96.7% View Chart
Dividend Yield % 0.6 0.6 101.4%  

Financials

 AJANTA PHARMA   CADILA HEALTHCARE
EQUITY SHARE DATA
    AJANTA PHARMA
Mar-16
CADILA HEALTHCARE
Mar-16
AJANTA PHARMA/
CADILA HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs1,720454 378.5%   
Low Rs1,103305 362.2%   
Sales per share (Unadj.) Rs194.696.1 202.5%  
Earnings per share (Unadj.) Rs45.214.9 304.0%  
Cash flow per share (Unadj.) Rs50.317.8 282.2%  
Dividends per share (Unadj.) Rs8.003.20 250.0%  
Dividend yield (eoy) %0.60.8 67.2%  
Book value per share (Unadj.) Rs132.052.3 252.6%  
Shares outstanding (eoy) m88.771,023.74 8.7%   
Bonus/Rights/Conversions -FV5:1-  
Price / Sales ratio x7.33.9 183.7%   
Avg P/E ratio x31.225.5 122.3%  
P/CF ratio (eoy) x28.121.3 131.8%  
Price / Book Value ratio x10.77.3 147.3%  
Dividend payout %17.721.5 82.2%   
Avg Mkt Cap Rs m125,299388,458 32.3%   
No. of employees `000NA15.4 0.0%   
Total wages/salary Rs m2,57013,317 19.3%   
Avg. sales/employee Rs ThNM6,371.1-  
Avg. wages/employee Rs ThNM862.4-  
Avg. net profit/employee Rs ThNM986.1-  
INCOME DATA
Net Sales Rs m17,27598,376 17.6%  
Other income Rs m166941 17.7%   
Total revenues Rs m17,44299,317 17.6%   
Gross profit Rs m5,80723,829 24.4%  
Depreciation Rs m4513,022 14.9%   
Interest Rs m49486 10.1%   
Profit before tax Rs m5,47421,262 25.7%   
Minority Interest Rs m0-300 0.0%   
Prior Period Items Rs m05 0.0%   
Extraordinary Inc (Exp) Rs m0-25 0.0%   
Tax Rs m1,4605,716 25.5%   
Profit after tax Rs m4,01415,226 26.4%  
Gross profit margin %33.624.2 138.8%  
Effective tax rate %26.726.9 99.2%   
Net profit margin %23.215.5 150.1%  
BALANCE SHEET DATA
Current assets Rs m7,63944,376 17.2%   
Current liabilities Rs m2,71534,071 8.0%   
Net working cap to sales %28.510.5 272.1%  
Current ratio x2.81.3 216.0%  
Inventory Days Days4354 80.3%  
Debtors Days Days7962 126.2%  
Net fixed assets Rs m6,91447,896 14.4%   
Share capital Rs m1771,024 17.3%   
"Free" reserves Rs m11,44248,746 23.5%   
Net worth Rs m11,72153,519 21.9%   
Long term debt Rs m1498,964 1.7%   
Total assets Rs m14,814100,163 14.8%  
Interest coverage x112.944.7 252.4%   
Debt to equity ratio x00.2 7.6%  
Sales to assets ratio x1.21.0 118.7%   
Return on assets %27.415.7 174.8%  
Return on equity %34.228.4 120.4%  
Return on capital %46.534.3 135.7%  
Exports to sales %55.145.3 121.8%   
Imports to sales %6.05.9 101.2%   
Exports (fob) Rs m9,52744,537 21.4%   
Imports (cif) Rs m1,0385,838 17.8%   
Fx inflow Rs m10,42244,881 23.2%   
Fx outflow Rs m1,6789,069 18.5%   
Net fx Rs m8,74435,812 24.4%   
CASH FLOW
From Operations Rs m3,26419,938 16.4%  
From Investments Rs m-2,093-9,039 23.2%  
From Financial Activity Rs m-1,186-9,527 12.4%  
Net Cashflow Rs m-151,372 -1.1%  

Share Holding

Indian Promoters % 73.8 74.8 98.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 1.6 8.3 18.7%  
FIIs % 7.6 5.9 128.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.0 11.0 154.5%  
Shareholders   20,968 44,069 47.6%  
Pledged promoter(s) holding % 4.4 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AJANTA PHARMA With:   FRESENIUS KABI ONCO.  DIVIS LABORATORIES  ALEMBIC LTD  ALEMBIC PHARMA  ELDER PHARMA  

Compare AJANTA PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Trade Marginally Higher; Pharma Sector Up 2.4%(11:30 am)

Stock markets in India are presently trading near the dotted line with positive bias. Sectoral indices are trading on a mixed note with stocks in the healthcare sector.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

Dear PM Modi, India is Already Land of Self-Employed, and It Ain't Working(Vivek Kaul's Diary)

Aug 21, 2017

Most Indians who cannot find jobs, look at becoming self-employed.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

Think Twice Before You Keep Money In A Savings Bank Account(Outside View)

Aug 22, 2017

Post demonetisation, a cut in bank savings deposits rates was in the offing.

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

AJANTA PHARMA SHARE PRICE


Aug 24, 2017 12:24 PM

TRACK AJANTA PHARMA

  • Track your investment in AJANTA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AJANTA PHARMA 5-YR ANALYSIS

COMPARE AJANTA PHARMA WITH

MARKET STATS